Aspira Women’s Health (NASDAQ:AWH) Research Coverage Started at StockNews.com

Posted by Defense World Staff on May 3rd, 2024

StockNews.com assumed coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the stock.

Separately, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $3.30 price objective on shares of Aspira Women’s Health in a research report on Wednesday, April 10th.

Read Our Latest Report on Aspira Women’s Health

Aspira Women’s Health Stock Performance

Shares of AWH opened at $3.21 on Friday. The company has a 50-day simple moving average of $3.49 and a 200-day simple moving average of $3.95. The firm has a market capitalization of $39.65 million, a P/E ratio of -0.27 and a beta of 1.57. Aspira Women’s Health has a 52 week low of $2.31 and a 52 week high of $6.75.

Aspira Women’s Health (NASDAQ:AWH – Get Free Report) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.09. The business had revenue of $2.13 million during the quarter, compared to analyst estimates of $2.70 million. Aspira Women’s Health had a negative net margin of 176.74% and a negative return on equity of 1,099.32%. As a group, equities analysts forecast that Aspira Women’s Health will post -1.24 earnings per share for the current year.

Institutional Trading of Aspira Women’s Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Northeast Financial Consultants Inc bought a new stake in Aspira Women’s Health in the third quarter valued at about $126,000. Quantum Private Wealth LLC grew its stake in Aspira Women’s Health by 76.8% during the fourth quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock worth $205,000 after buying an additional 21,788 shares during the last quarter. Perkins Capital Management Inc. bought a new stake in Aspira Women’s Health during the third quarter worth about $268,000. Finally, B. Riley Wealth Advisors Inc. grew its stake in Aspira Women’s Health by 39.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock worth $672,000 after buying an additional 35,177 shares during the last quarter. Institutional investors own 12.19% of the company’s stock.

About Aspira Women’s Health

(Get Free Report)

Aspira Women’s Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company’s products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.